top of page
Top News
Akamis Bio Header Image

Our News

Akamis Bio’s latest news, events and updates.

October 3, 2023

Akamis Bio Highlights Data Showing Potential of its Adenovirus Vector Technology in Combination with Radiation to Treat Advanced Rectal Cancer

July 6, 2023

Akamis Bio Strengthens Leadership Team with Key Executive Appointments

February 16, 2023

Akamis Bio, Parker Institute for Cancer Immunotherapy and Cancer Research Institute
Announce Expanded Partnership to Advance Novel Treatments for Pancreatic Cancer

January 5, 2023

Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics

August 11, 2022

PsiOxus Therapeutics Appoints Howard Davis, Ph.D. as Chief Executive Officer

bottom of page